Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo‐controlled study of effects on coagulation and fibrinolytic factors
- 6 March 2001
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 249 (3) , 237-246
- https://doi.org/10.1111/j.1365-2796.2001.00797.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Estrogen replacement therapy and coagulation: Relationship to lipid and lipoprotein changesPublished by Wolters Kluwer Health ,1998
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Prospective study of exogenous hormones and risk of pulmonary embolism in womenThe Lancet, 1996
- The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal statusAmerican Journal of Obstetrics and Gynecology, 1995
- von Willebrand factor and its relevance to cardiovascular disorders.Heart, 1995
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986